Data from Israel: Myocarditis after COVID-19 vaccines remain rare, highest risk in young males
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after a third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according ...
Sep 5, 2022
0
28